Javascript must be enabled to continue!
#6559 THE ROLE OF MEDIUM-CHAIN FATTY ACIDS IN RENAL METABOLISM AND DISEASES
View through CrossRef
Abstract
Background and Aims
Through metabolomics research, it was found that in mice with chronic kidney disease, the distribution of lipids in the kidneys was different from that of healthy individuals, and medium-chain fatty acids were reduced. In order to explore the role of medium-chain fatty acids in kidney metabolism and disease, we conducted this systematic review.
Method
Systematic review. The pubmed database was used to search for keywords such as medium chain fat acids, medium chain triglyceride, MCFA, MCT, chronic kidney disease, CKD, and renal fibrosis.
Results
In chronic kidney disease, long-chain fatty acids decrease and medium-chain fatty acids increase. The increase of medium-chain fatty acids may be a compensatory mechanism. Compared with long-chain fatty acids, medium-chain fatty acids are more easily metabolized through the tricarboxylic acid cycle, thus providing more energy. MCFAs are readily oxidized by cells,including cardiomyocytes, and provide a very efficient. source of energy production. MCFAs display metabolic,biological and physical properties that are distinct fromLCFAs, which may contribute to their reported benefits on the kidney's energy status and function. Only few deleterious effects have been reported with the use of MCFAs, many of which have been reported mainly when MCTs were administered as the main dietary energy source representing >50% of the total energy intake. These include decreased absorption of LCTs, which may result in deficiency in essential polyunsaturated LCFA, steatorrhea, gastrointestinal discomfort, increased risk of ketogenesis and acidosis, and in some studies, though not all, changes in blood lipid profile such as a raise in triglycerides or nonhigh-density lipoprotein cholesterol
Conclusion
Studies in animal models indicate that MCFAs may favourably modulate kidney disease progression. Medium-chain fatty acids have protective effects on the kidney and provide new ideas for the relief and treatment of chronic kidney disease.
Title: #6559 THE ROLE OF MEDIUM-CHAIN FATTY ACIDS IN RENAL METABOLISM AND DISEASES
Description:
Abstract
Background and Aims
Through metabolomics research, it was found that in mice with chronic kidney disease, the distribution of lipids in the kidneys was different from that of healthy individuals, and medium-chain fatty acids were reduced.
In order to explore the role of medium-chain fatty acids in kidney metabolism and disease, we conducted this systematic review.
Method
Systematic review.
The pubmed database was used to search for keywords such as medium chain fat acids, medium chain triglyceride, MCFA, MCT, chronic kidney disease, CKD, and renal fibrosis.
Results
In chronic kidney disease, long-chain fatty acids decrease and medium-chain fatty acids increase.
The increase of medium-chain fatty acids may be a compensatory mechanism.
Compared with long-chain fatty acids, medium-chain fatty acids are more easily metabolized through the tricarboxylic acid cycle, thus providing more energy.
MCFAs are readily oxidized by cells,including cardiomyocytes, and provide a very efficient.
source of energy production.
MCFAs display metabolic,biological and physical properties that are distinct fromLCFAs, which may contribute to their reported benefits on the kidney's energy status and function.
Only few deleterious effects have been reported with the use of MCFAs, many of which have been reported mainly when MCTs were administered as the main dietary energy source representing >50% of the total energy intake.
These include decreased absorption of LCTs, which may result in deficiency in essential polyunsaturated LCFA, steatorrhea, gastrointestinal discomfort, increased risk of ketogenesis and acidosis, and in some studies, though not all, changes in blood lipid profile such as a raise in triglycerides or nonhigh-density lipoprotein cholesterol
Conclusion
Studies in animal models indicate that MCFAs may favourably modulate kidney disease progression.
Medium-chain fatty acids have protective effects on the kidney and provide new ideas for the relief and treatment of chronic kidney disease.
Related Results
Amino Acids, Survey
Amino Acids, Survey
AbstractAmino acids are the main components of proteins. Approximately 20 amino acids are common constituents of proteins and are called protein amino acids, or primary protein ami...
Amino Acids
Amino Acids
AbstractAmino acids are the main components of proteins. Approximately 20 amino acids are common constituents of proteins and are called protein amino acids, or primary protein ami...
Fatty Acids: Structures and Properties
Fatty Acids: Structures and Properties
AbstractFatty acids are carbon chains with a methyl group at one end of the molecule and a carboxyl group at the other end that are either saturated or unsaturated. They are essent...
Study on Anatomycal Structure of Watergum Wood (<i>Syzygium </i>sp.)
Study on Anatomycal Structure of Watergum Wood (<i>Syzygium </i>sp.)
<!--[if gte mso 9]><xml> <w:WordDocument> <w:View>Normal</w:View> <w:Zoom>0</w:Zoom> <w:TrackMoves /> <w:TrackFormatting /> &l...
Cometary Physics Laboratory: spectrophotometric experiments
Cometary Physics Laboratory: spectrophotometric experiments
<p><strong><span dir="ltr" role="presentation">1. Introduction</span></strong&...
IN VITRO HYPOGLYCEMIC AND ANTIMICROBIAL ACTIVITY OF CUCUMIS CALLOSUS (ROTTL.) COGN. FRUIT
IN VITRO HYPOGLYCEMIC AND ANTIMICROBIAL ACTIVITY OF CUCUMIS CALLOSUS (ROTTL.) COGN. FRUIT
<!--[if gte mso 9]><xml>
<o:OfficeDocumentSettings>
<o:RelyOnVML/>
<o:AllowPNG/>
</o:OfficeDocumentSettings>
...
Blunt Chest Trauma and Chylothorax: A Systematic Review
Blunt Chest Trauma and Chylothorax: A Systematic Review
Abstract
Introduction: Although traumatic chylothorax is predominantly associated with penetrating injuries, instances following blunt trauma, as a rare and challenging condition, ...
Ethno-botany of Dasigo Tribe of Mamberamo in Papua
Ethno-botany of Dasigo Tribe of Mamberamo in Papua
<!--[if gte mso 9]><xml> <w:WordDocument> <w:View>Normal</w:View> <w:Zoom>0</w:Zoom> <w:TrackMoves /> <w:TrackFormatting /> &l...

